Pesquisa

Edição
Título
Autores
Nº 20 (2014)
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.
PDF
(Rus)
Volume 30, Nº 3 (2023)
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.
PDF
(Rus)
Nº 10 (2012)
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A., Valitov B., Chernikova N., Antsiferov M.
PDF
(Rus)
Nº 5 (2017)
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
PDF
(Rus)
Nº 11 (2012)
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.
PDF
(Rus)
Volume 29, Nº 4 (2022)
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
PDF
(Rus)
Nº 3 (2012)
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
Nº 3 (2012)
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
Volume 30, Nº 12 (2023)
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.
PDF
(Rus)
Volume 28, Nº 12 (2021)
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Novikova M., Demidov N.
PDF
(Rus)
Nº 16 (2013)
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.
PDF
(Rus)
Nº 5 (2013)
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.
PDF
(Rus)
Volume 30, Nº 12 (2023)
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N., Knyshenko O., Ivanova L.
PDF
(Rus)
Nº 5 (2015)
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.
PDF
(Rus)
Nº 5 (2017)
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.
PDF
(Rus)
Volume 27, Nº 4 (2020)
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.
PDF
(Rus)
Nº 16 (2010)
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A., Mkrtumyan A.
Volume 31, Nº 8 (2024)
Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone
Elsukova O., Nikitina E.
PDF
(Rus)
Volume 32, Nº 2 (2025)
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T., Vezikova N.
PDF
(Rus)
Volume 30, Nº 12 (2023)
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N., Degtyareva E.
PDF
(Rus)
Volume 29, Nº 4 (2022)
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
PDF
(Rus)
Volume 27, Nº 4 (2020)
The many faces of vitamin D
Verbovoy A., Dolgikh Y., Verbovaya N.
PDF
(Rus)
Volume 26, Nº 4 (2019)
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
PDF
(Rus)
Nº 11 (2018)
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A., Lomonova T., Sharonova L.
PDF
(Rus)
Nº 16 (2017)
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.
PDF
(Rus)
Nº 5 (2017)
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N., Antsiferov M., Dorofeeva L.
PDF
(Rus)
Nº 16 (2016)
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PDF
(Rus)
Nº 17 (2015)
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
PDF
(Rus)
Nº 5 (2015)
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M., Koteshkova O.
PDF
(Rus)
Nº 16 (2014)
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
PDF
(Rus)
Nº 5 (2013)
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E., Rashid M., Antsiferov M.
PDF
(Rus)
Nº 16 (2012)
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
PDF
(Rus)
Nº 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
Nº 3 (2012)
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Nº 16 (2010)
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.
Nº 16 (2010)
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T., Demidova T.
Nº 3 (2010)
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.
Volume 31, Nº 8 (2024)
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.
PDF
(Rus)
Volume 30, Nº 12 (2023)
News of medicine
Kudinova S.
PDF
(Rus)
Volume 30, Nº 12 (2023)
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.
PDF
(Rus)
Volume 30, Nº 3 (2023)
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.
PDF
(Rus)
Volume 28, Nº 12 (2021)
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N., Panenko S., Golubeva A.
PDF
(Rus)
Volume 28, Nº 3 (2021)
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
PDF
(Rus)
Volume 27, Nº 12 (2020)
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
PDF
(Rus)
Volume 26, Nº 14 (2019)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
PDF
(Rus)
Volume 26, Nº 4 (2019)
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.
PDF
(Rus)
Nº 4 (2018)
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
PDF
(Rus)
Nº 16 (2017)
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E., Antsiferov M.
PDF
(Rus)
Nº 5 (2017)
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
PDF
(Rus)
Nº 16 (2016)
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
PDF
(Rus)
Nº 17 (2015)
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
PDF
(Rus)
Nº 5 (2015)
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
PDF
(Rus)
Nº 16 (2014)
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
PDF
(Rus)
Nº 16 (2013)
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
PDF
(Rus)
Nº 16 (2012)
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
PDF
(Rus)
Nº 5 (2011)
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
Nº 16 (2010)
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O., Zanozina O.
Nº 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
Volume 31, Nº 8 (2024)
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
Kurnikova I., Chekalina M., Ualikhanova A.
PDF
(Rus)
Volume 31, Nº 2 (2024)
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.
PDF
(Rus)
Volume 30, Nº 12 (2023)
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.
PDF
(Rus)
Volume 30, Nº 3 (2023)
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E., Shinkin M., Morozova I.
PDF
(Rus)
Volume 29, Nº 4 (2022)
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.
PDF
(Rus)
Volume 27, Nº 12 (2020)
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
PDF
(Rus)
Volume 26, Nº 14 (2019)
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
PDF
(Rus)
Volume 26, Nº 4 (2019)
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G., Novikova L.
PDF
(Rus)
Nº 11 (2018)
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y., Zanozin A., Zanozina O., Runov G.
PDF
(Rus)
Nº 4 (2018)
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.
PDF
(Rus)
Nº 16 (2017)
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
PDF
(Rus)
Nº 5 (2016)
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.
PDF
(Rus)
Nº 17 (2015)
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.
PDF
(Rus)
Nº 5 (2015)
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N., Ivanova L., Abaeva F.
PDF
(Rus)
Nº 16 (2014)
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
PDF
(Rus)
Nº 16 (2013)
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
PDF
(Rus)
Nº 16 (2013)
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E., Danilova T.
PDF
(Rus)
Nº 5 (2013)
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
PDF
(Rus)
Nº 11 (2012)
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PDF
(Rus)
Nº 3 (2012)
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
Nº 3 (2011)
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I., Romantsova T., Glinkina I., Romantsova T.
Nº 16 (2010)
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A., Rudakova A.
Nº 3 (2010)
Advance - movement forward
Petunina N., Petunina N.
Volume 32, Nº 2 (2025)
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children
Sadykova D., Shaydullina M., Aksenova A., Galimova L.
PDF
(Rus)
Volume 31, Nº 2 (2024)
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
Demicheva T.
PDF
(Rus)
Volume 30, Nº 12 (2023)
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
PDF
(Rus)
Volume 30, Nº 12 (2023)
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
PDF
(Rus)
Volume 29, Nº 11/12 (2022)
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.
PDF
(Rus)
Volume 28, Nº 12 (2021)
Carbohydrate metabolism disorders and osteoporosis
Alekseeva N.
PDF
(Rus)
Volume 27, Nº 12 (2020)
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.
PDF
(Rus)
Volume 26, Nº 4 (2019)
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N., Mishra O., Antsiferov M.
PDF
(Rus)
Nº 4 (2018)
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.
PDF
(Rus)
Nº 6 (2017)
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.
PDF
(Rus)
Nº 5 (2016)
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
PDF
(Rus)
Nº 17 (2015)
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
PDF
(Rus)
Nº 5 (2015)
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
PDF
(Rus)
Nº 16 (2014)
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
PDF
(Rus)
Nº 16 (2013)
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A., Tertychnaya E.
PDF
(Rus)
Nº 5 (2013)
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L., Lomova A., Ruyatkin D.
PDF
(Rus)
1 - 100 de 185 resultados 1 2 > >> 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.